These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7523197)

  • 21. The histone deacetylase inhibitor trichostatin A downregulates human MDR1 (ABCB1) gene expression by a transcription-dependent mechanism in a drug-resistant small cell lung carcinoma cell line model.
    El-Khoury V; Breuzard G; Fourré N; Dufer J
    Br J Cancer; 2007 Aug; 97(4):562-73. PubMed ID: 17667922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of RANKL promoter activity is associated with histone remodeling in murine bone stromal cells.
    Fan X; Roy EM; Murphy TC; Nanes MS; Kim S; Pike JW; Rubin J
    J Cell Biochem; 2004 Nov; 93(4):807-18. PubMed ID: 15389882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y; Fatima N; Dufau ML
    Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histone hyperacetylation plays a role in augmentation of IL-4-induced IgE production in LPS-stimulated murine B-lymphocytes by sodium butyrate.
    Yamamoto I; Matsunaga T; Sakata K; Nakamura Y; Doi S; Hanmyou F
    J Biochem; 1996 Jun; 119(6):1056-61. PubMed ID: 8827437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The immunoglobulin heavy chain locus control region increases histone acetylation along linked c-myc genes.
    Madisen L; Krumm A; Hebbes TR; Groudine M
    Mol Cell Biol; 1998 Nov; 18(11):6281-92. PubMed ID: 9774645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of the tyrosine hydroxylase gene promoter by histone deacetylase inhibitors.
    Kim HS; Park JS; Hong SJ; Woo MS; Kim SY; Kim KS
    Biochem Biophys Res Commun; 2003 Dec; 312(4):950-7. PubMed ID: 14651963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of complement component (C3 and factor B) biosynthesis by a histone deacetylase inhibitor in human intestinal epithelial cells.
    Andoh A; Fujiyama Y; Shimada M; Bamba T
    Int J Mol Med; 2000 Jul; 6(1):51-4. PubMed ID: 10851266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate.
    Sekhavat A; Sun JM; Davie JR
    Biochem Cell Biol; 2007 Dec; 85(6):751-8. PubMed ID: 18059533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Keratin 23 (K23), a novel acidic keratin, is highly induced by histone deacetylase inhibitors during differentiation of pancreatic cancer cells.
    Zhang JS; Wang L; Huang H; Nelson M; Smith DI
    Genes Chromosomes Cancer; 2001 Feb; 30(2):123-35. PubMed ID: 11135429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas.
    Duan H; Heckman CA; Boxer LM
    Mol Cell Biol; 2005 Mar; 25(5):1608-19. PubMed ID: 15713621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histone deacetylase inhibitors promote osteoblast maturation.
    Schroeder TM; Westendorf JJ
    J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell growth inhibition and gene expression induced by the histone deacetylase inhibitor, trichostatin A, on human hepatoma cells.
    Chiba T; Yokosuka O; Fukai K; Kojima H; Tada M; Arai M; Imazeki F; Saisho H
    Oncology; 2004; 66(6):481-91. PubMed ID: 15452378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histone deacetylase inhibitors interfere with angiogenesis by decreasing endothelial VEGFR-2 protein half-life in part via a VE-cadherin-dependent mechanism.
    Hrgovic I; Doll M; Pinter A; Kaufmann R; Kippenberger S; Meissner M
    Exp Dermatol; 2017 Feb; 26(2):194-201. PubMed ID: 27487811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer.
    Cameron EE; Bachman KE; Myöhänen S; Herman JG; Baylin SB
    Nat Genet; 1999 Jan; 21(1):103-7. PubMed ID: 9916800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of MMTV transcription by HDAC inhibitors occurs independent of changes in chromatin remodeling and increased histone acetylation.
    Mulholland NM; Soeth E; Smith CL
    Oncogene; 2003 Jul; 22(31):4807-18. PubMed ID: 12894222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histone deacetylase inhibitor activates the p21/WAF1/Cip1 gene promoter through the Sp1 sites.
    Sowa Y; Orita T; Hiranabe-Minamikawa S; Nakano K; Mizuno T; Nomura H; Sakai T
    Ann N Y Acad Sci; 1999; 886():195-9. PubMed ID: 10667218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possible mechanism of action of the histone deacetylase inhibitors for the induction of differentiation of HL-60 clone 15 cells into eosinophils.
    Ishihara K; Hong J; Zee O; Ohuchi K
    Br J Pharmacol; 2004 Jul; 142(6):1020-30. PubMed ID: 15210580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amplification of recombinant adenoviral transgene products occurs by inhibition of histone deacetylase.
    Dion LD; Goldsmith KT; Tang DC; Engler JA; Yoshida M; Garver RI
    Virology; 1997 May; 231(2):201-9. PubMed ID: 9168882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histone deacetylase inhibition is associated with transcriptional repression of the Hmga2 gene.
    Ferguson M; Henry PA; Currie RA
    Nucleic Acids Res; 2003 Jun; 31(12):3123-33. PubMed ID: 12799440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of histone deacetylation by butyrate induces morphological changes in Y79 retinoblastoma cells.
    Karasawa Y; Okisaka S
    Jpn J Ophthalmol; 2004; 48(6):542-51. PubMed ID: 15592778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.